JP2009132712A5 - - Google Patents

Download PDF

Info

Publication number
JP2009132712A5
JP2009132712A5 JP2008298513A JP2008298513A JP2009132712A5 JP 2009132712 A5 JP2009132712 A5 JP 2009132712A5 JP 2008298513 A JP2008298513 A JP 2008298513A JP 2008298513 A JP2008298513 A JP 2008298513A JP 2009132712 A5 JP2009132712 A5 JP 2009132712A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
drug
surfactant
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008298513A
Other languages
English (en)
Japanese (ja)
Other versions
JP5491724B2 (ja
JP2009132712A (ja
Filing date
Publication date
Priority claimed from US11/944,239 external-priority patent/US20090130198A1/en
Application filed filed Critical
Publication of JP2009132712A publication Critical patent/JP2009132712A/ja
Publication of JP2009132712A5 publication Critical patent/JP2009132712A5/ja
Application granted granted Critical
Publication of JP5491724B2 publication Critical patent/JP5491724B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008298513A 2007-11-21 2008-11-21 生物学的利用能を向上した医薬組成物 Expired - Fee Related JP5491724B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/944,239 2007-11-21
US11/944,239 US20090130198A1 (en) 2007-11-21 2007-11-21 Pharmaceutical composition with enhanced bioavailability

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014038075A Division JP2014098039A (ja) 2007-11-21 2014-02-28 生物学的利用能を向上した医薬組成物

Publications (3)

Publication Number Publication Date
JP2009132712A JP2009132712A (ja) 2009-06-18
JP2009132712A5 true JP2009132712A5 (enExample) 2011-11-10
JP5491724B2 JP5491724B2 (ja) 2014-05-14

Family

ID=40439733

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008298513A Expired - Fee Related JP5491724B2 (ja) 2007-11-21 2008-11-21 生物学的利用能を向上した医薬組成物
JP2014038075A Pending JP2014098039A (ja) 2007-11-21 2014-02-28 生物学的利用能を向上した医薬組成物
JP2016053870A Pending JP2016106152A (ja) 2007-11-21 2016-03-17 生物学的利用能を向上した医薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014038075A Pending JP2014098039A (ja) 2007-11-21 2014-02-28 生物学的利用能を向上した医薬組成物
JP2016053870A Pending JP2016106152A (ja) 2007-11-21 2016-03-17 生物学的利用能を向上した医薬組成物

Country Status (5)

Country Link
US (1) US20090130198A1 (enExample)
EP (1) EP2062571B8 (enExample)
JP (3) JP5491724B2 (enExample)
CN (1) CN101439015B (enExample)
ES (1) ES2396723T3 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ592970A (en) * 2008-12-03 2013-05-31 Astellas Deutschland Gmbh Oral dosage forms of bendamustine
DK2519261T3 (da) 2009-12-28 2014-02-03 Reig Jofre S A Lab Flydende oralt farmaceutisk præparat, som er en opløsning omfattende nifedipin.
SG10201503234SA (en) 2010-05-03 2015-06-29 Teikoku Pharma Usa Inc Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same
MY158809A (en) * 2010-09-22 2016-11-15 Craun Res Sdn Bhd Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
CN102389401B (zh) * 2011-11-22 2013-05-22 陆荣政 一种右旋布洛芬颗粒及其制备方法
KR101211902B1 (ko) * 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN109953954A (zh) 2013-08-27 2019-07-02 V·沃道里斯 苯达莫司汀医药组合物
RU2746548C2 (ru) * 2014-11-04 2021-04-15 Иннофармакс, Инк. Пероральное введение неустойчивых или плохо всасывающихся лекарственных средств
EP3337463A4 (en) * 2015-08-19 2019-04-03 Vivus, Inc. PHARMACEUTICAL FORMULATIONS
JP6103111B1 (ja) 2016-05-24 2017-03-29 三生医薬株式会社 経口医薬組成物及び該組成物からなる粒子状製剤の製造方法
JP2020152674A (ja) * 2019-03-20 2020-09-24 株式会社リコー 難水溶性化合物の可溶化物の製造方法
KR102676428B1 (ko) * 2019-07-08 2024-06-19 가부시키가이샤 모레스코 마이크로에멀션을 조제하기 위한 조성물, 마이크로에멀션, 이들의 제조 방법, 및 마이크로에멀션의 이용

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
AU1766592A (en) * 1991-06-03 1993-01-08 Merck Sharp & Dohme Limited Pharmaceutical formulations of a benzodiazepine
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5965160A (en) * 1995-04-24 1999-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
JP3009742B2 (ja) * 1995-08-25 2000-02-14 サングスタット メディカル コーポレイション 経口用シクロスポリン製剤
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR20040004416A (ko) * 1997-01-30 2004-01-13 노파르티스 아게 오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
DE69822814T2 (de) * 1998-08-18 2005-01-27 Panacea Biotec Ltd. Zusammensetzung enthaltend Cyclosporin in einem hydrophilen Träger
CN1236813C (zh) * 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
DE10133305B4 (de) * 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat
US6960563B2 (en) * 2001-08-31 2005-11-01 Morton Grove Pharmaceuticals, Inc. Spontaneous emulsions containing cyclosporine
JP2005343799A (ja) * 2004-05-31 2005-12-15 Nisshin Oillio Group Ltd 水分散性植物ステロース製剤と油脂含有水分散性植物ステロール製剤
KR100678829B1 (ko) * 2004-12-06 2007-02-05 한미약품 주식회사 타크로리무스의 경구용 마이크로에멀젼 조성물

Similar Documents

Publication Publication Date Title
JP2009132712A5 (enExample)
He et al. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs
Wadhwa et al. Emulsion forming drug delivery system for lipophilic drugs
Harwansh et al. Nanoemulsion: Promising nanocarrier system for delivery of herbal bioactives
Date et al. Parenteral microemulsions: an overview
Talegaonkar et al. Microemulsions: a novel approach to enhanced drug delivery
Pathak et al. Oral bioavailability: issues and solutions via nanoformulations
Negi et al. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique
Onoue et al. Nanodrugs: pharmacokinetics and safety
Win et al. In vitro and in vivo studies on vitamin E TPGS-emulsified poly (D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation
JP4695260B2 (ja) 抗癌組成物
Tatham et al. Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics
JP2003530314A5 (enExample)
CN103249403A (zh) 胡桐素及胡桐素衍生物和类似物的药物组合物及其制备方法
CA2478424A1 (en) Self emulsifying drug delivery systems for poorly soluble drugs
CN1261796A (zh) 自体乳化剂形式的酸性亲脂性化合物的药物组合物
CN102307576A (zh) 用于增强水不溶性活性剂的释放和吸收的方法
JP2015504924A5 (enExample)
CN101439015A (zh) 有增进生物可利用性的医药组合物
Singh Self-nanoemulsifying drug delivery system: A versatile carrier for lipophilic drugs
ES2210056T3 (es) Preconcentrados en microemulsion y microemulsiones que contienen coenzima q10.
RU2013126259A (ru) Фармацевтическая композиция таксоидов
Zakaria et al. Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: factorial design, in-vitro and in-vivo assessments
WO2015186039A1 (en) Oral pharmaceutical composition of isotretinoin
ES2551125T3 (es) Composición antifúngica